Instituto Nacional de Cancerologia de Mexico
52
13
15
21
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.9%
1 terminated/withdrawn out of 52 trials
95.5%
+9.0% vs industry average
6%
3 trials in Phase 3/4
24%
5 of 21 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (52)
Lung Cancer Screening for Early Detection of Suspicious Lung Nodules in Latin America(LUCAS-LATAM)
Role: collaborator
Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.
Role: lead
Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC
Role: lead
Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations
Role: lead
Tocilizumab Treatment in Patients With COVID-19
Role: lead
Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients
Role: lead
Alectinib Pharmacokinetic in Patients With NSCLC
Role: lead
Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients
Role: lead
Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery
Role: lead
Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC
Role: lead
Lung Cancer Screening Program in Mexico
Role: lead
Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer
Role: lead
Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)
Role: lead
Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer
Role: lead
Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab
Role: collaborator
Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients
Role: lead
Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population
Role: collaborator
Gastric Cancer Risk Factors Associated With EU and CELAC Populations
Role: collaborator
Advanced GC Multi-omic Characterization in EU and CELAC Populations
Role: collaborator
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Role: lead